Hove K, Horst R L, Littledike E T, Beitz D C
Endocrinology. 1984 Mar;114(3):897-903. doi: 10.1210/endo-114-3-897.
The relationship between infused synthetic bovine PTH-(1-34) and plasma concentrations of minerals and vitamin D metabolites was studied in eight calves (150-230 kg) and two thyroparathyroidectomized goats. Calves were infused iv with saline for 15-20 h. Then, calves were infused with one of three types of solution for an additional 35-h period. Three of the eight calves received 3 ng/kg X min (group H), three received 0.75 ng/kg X min (group L), and the remaining two calves received control saline over a 33-h period (group C). Blood samples were taken every 4-6 h. Plasma calcium, phosphorus, hydroxyproline, and 1,25-dihydroxyvitamin D [1,25-(OH)2D] remained relatively constant in control calves. PTH infusions into calves in group H resulted in an increase in plasma calcium from 2.4 to a plateau of 3.0 mmol/liter. PTH infusion caused no change in plasma phosphorus, but increased urinary excretion of phosphorus. Infusion of PTH caused a moderate increase in urinary calcium excretion, followed by pronounced calciuria after PTH withdrawal. Plasma concentrations of 1,25-(OH)2D decreased from about 30 pg/ml at the start of infusion to undetectable levels (less than 5 pg/ml) at the end of the infusion and for 30 h thereafter. Similar, but less pronounced, changes in plasma calcium and 1,25-(OH)2D concentration were observed in group L. Hypocalcemia and hypophosphatemia developed in the two lactating goats after thyroparathyroidectomy, and plasma 1,25-(OH)2D concentrations were decreased. PTH infusion (3 ng/kg X min) corrected the hypocalcemia and hypophosphatemia and markedly raised plasma 1,25-(OH)2D concentrations. When calcium chloride was infused in addition to PTH, the resulting hypercalcemia (3 mmol/liter) was associated with a marked reduction in plasma 1,25-(OH)2D. We conclude that the concentration of calcium in plasma has the major regulatory role on plasma 1,25-(OH)2D concentrations in ruminant species when potentially conflicting signals, such as hypercalcemia and high PTH concentrations, are present simultaneously.
在八头小牛(150 - 230千克)和两只甲状旁腺切除的山羊中研究了静脉输注合成牛甲状旁腺激素(1 - 34)与矿物质及维生素D代谢产物血浆浓度之间的关系。小牛静脉输注生理盐水15 - 20小时。然后,小牛再接受三种溶液中的一种额外输注35小时。八头小牛中的三头接受3纳克/千克×分钟(H组),三头接受0.75纳克/千克×分钟(L组),其余两头小牛在33小时内接受对照生理盐水(C组)。每4 - 6小时采集血样。对照小牛的血浆钙、磷、羟脯氨酸和1,25 - 二羟基维生素D [1,25 - (OH)₂D]保持相对恒定。H组小牛输注甲状旁腺激素导致血浆钙从2.4毫摩尔/升升高至3.0毫摩尔/升的平台期。甲状旁腺激素输注未引起血浆磷变化,但增加了磷的尿排泄。甲状旁腺激素输注导致尿钙排泄适度增加,甲状旁腺激素撤药后出现明显的高钙尿。血浆1,25 - (OH)₂D浓度从输注开始时的约30皮克/毫升降至输注结束时及之后30小时的不可检测水平(低于5皮克/毫升)。L组观察到血浆钙和1,25 - (OH)₂D浓度有类似但不太明显的变化。两只泌乳山羊甲状旁腺切除后出现低钙血症和低磷血症,血浆1,25 - (OH)₂D浓度降低。甲状旁腺激素输注(3纳克/千克×分钟)纠正了低钙血症和低磷血症,并显著提高了血浆1,25 - (OH)₂D浓度。当除甲状旁腺激素外还输注氯化钙时,由此产生的高钙血症(3毫摩尔/升)与血浆1,25 - (OH)₂D的显著降低相关。我们得出结论,当同时存在潜在冲突信号,如高钙血症和高甲状旁腺激素浓度时,血浆钙浓度对反刍动物血浆1,25 - (OH)₂D浓度起主要调节作用。